Index of medicine substances

Saccharomyces boulardii  •  Alimentary tract and metabolism | Antidiarrheal microorganisms (A07FA02)

Sacituzumab govitecan  •  Antineoplastic and immunomodulating agents | Monoclonal antibodies and antibody drug conjugates | Other monoclonal antibodies and antibody drug conjugates (L01FX17)

Sacrosidas  •  Alimentary tract and metabolism | Other alimentary tract and metabolism products | Other alimentary tract and metabolism products | Enzymes (A16AB06)

Sacubitril + valsartan  •  Cardiovascular system | Angiotensin II receptor blockers (ARBs), combinations | Angiotensin ii receptor blockers (arbs), other combinations (C09DX04)

Salbutamol  •  Respiratory system | Adrenergics for systemic use | Selective beta-2-adrenoreceptor agonists (R03CC02)

Salicylic acid  •  Dermatologicals | Other dermatological preparations | Other dermatological preparations | Wart and anti-corn preparations (D11AFN1)

Salicylic acid + glacial acetic acid  •  Dermatologicals | Other dermatological preparations | Other dermatological preparations | Wart and anti-corn preparations (D11AFN1)

Salicylic acid + lactic acid  •  Musculo-skeletal system | Topical products for joint and muscular pain | Topical products for joint and muscular pain | Preparations with salicylic acid derivatives (M02ACN2)

Salmeterol  •  Respiratory system | Adrenergics, inhalants | Selective beta-2-adrenoreceptor agonists (R03AC12)

Salmeterol + fluticasone  •  Respiratory system | Adrenergics, inhalants | Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics (R03AK06)

Samarium lexidronam pentasodium  •  Various | Pain palliation (bone seeking agents) | Various pain palliation radiopharmaceuticals (V10BX02)

Sapropterin  •  Alimentary tract and metabolism | Other alimentary tract and metabolism products | Other alimentary tract and metabolism products | Various alimentary tract and metabolism products (A16AX07)

Saquinavir  •  Antiinfectives for systemic use | Direct acting antivirals | Protease inhibitors (J05AE01)

Satralizumab  •  Antineoplastic and immunomodulating agents | Immunosuppressants | Immunosuppressants | Interleukin inhibitors (L04AC19)

Saxagliptin  •  Alimentary tract and metabolism | Blood glucose lowering drugs, excl. insulins | Dipeptidyl peptidase 4 (DDP-4) inhibitors (A10BH03)

Saxagliptin + dapagliflozin  •  Alimentary tract and metabolism | Blood glucose lowering drugs, excl. insulins | Combinations of oral blood glucose lowering drugs (A10BD21)

Saxagliptin + metformin  •  Alimentary tract and metabolism | Blood glucose lowering drugs, excl. insulins | Combinations of oral blood glucose lowering drugs (A10BD10)

Scots pine essential oil + eucalyptus + peppermint + tocopherol  •  Respiratory system | Decongestants and other nasal preparations for topical use | Other nasal preparations (R01AX10)

Sebelipase alfa  •  Alimentary tract and metabolism | Other alimentary tract and metabolism products | Other alimentary tract and metabolism products | Enzymes (A16AB14)

Secukinumab  •  Antineoplastic and immunomodulating agents | Immunosuppressants | Immunosuppressants | Interleukin inhibitors (L04AC10)

Seladelpar  •  Alimentary tract and metabolism | Bile therapy | Other drugs for bile therapy (A05AX07)

Selegiline  •  Nervous system | Dopaminergic agents | Monoamine oxidase B inhibitors (N04BD01)

Selenium  •  Alimentary tract and metabolism | Other mineral supplements | Selenium (A12CE02)

Selenium (75Se) tauroselcholic acid  •  Various | Hepatic and reticulo endothelial system | Other hepatic and reticulo endothelial system diagnostic radiopharmaceuticals (V09DX01)

Selexipag  •  Blood and blood forming organs | Antithrombotic agents | Antithrombotic agents | Platelet aggregation inhibitors excl. heparin (B01AC27)

Selpercatinib  •  Antineoplastic and immunomodulating agents | Protein kinase inhibitors | Other protein kinase inhibitors (L01EX22)

Selumetinib  •  Antineoplastic and immunomodulating agents | Protein kinase inhibitors | Mitogen-activated protein kinase (MEK) inhibitors (L01EE04)

Semaglutide  •  Alimentary tract and metabolism | Blood glucose lowering drugs, excl. insulins | Glucagon-like peptide-1 (GLP-1) analogues (A10BJ06)

Sennosides  •  Alimentary tract and metabolism | Drugs for constipation | Drugs for constipation | Contact laxatives (A06AB56)

Sepiapterin  •  Alimentary tract and metabolism | Other alimentary tract and metabolism products | Other alimentary tract and metabolism products | Various alimentary tract and metabolism products (A16AX28)